Ascendant Resources Announces August 2017 Operational Results
Sep 20, 2017 11:30 am UTC| Business
Second consecutive month of positive adjusted EBITDATonnes milled increased to 1,903 tpd, up 9.8% from Q2 average and 53% from January 2017Fleet renewal in-process with new equipment ordered TORONTO, Sept. 20, 2017 --...
Sep 20, 2017 11:30 am UTC| Business
- Actinium is now a member of the ASBMT™ Corporate Council - Two day event focused on facilitating dialogue aimed at advancing the field of bone marrow transplantation and cellular therapy NEW YORK, Sept. 20, 2017 --...
Merus’ Intellectual Property Portfolio Expands with Two New Patents For its Biclonics® Technology
Sep 20, 2017 11:30 am UTC| Business
UTRECHT, The Netherlands, Sept. 20, 2017 -- Merus (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing therapeutics with the goal of treating and curing serious illnesses, announced today that it has added...
Sep 20, 2017 11:30 am UTC| Business
Delivery Trust™ Email Encryption Service Provides Insurance Providers the Most Secure and Cost-Effective Way to Ensure Secure Communication Delivery Trust™ Email Encryption Service Provides Businesses the Most Effective...
OpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 20, 2017 11:30 am UTC| Business
GAITHERSBURG, Md., Sept. 20, 2017 -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2017...
Spark Therapeutics Enters into Licensing Agreement with Genethon
Sep 20, 2017 11:30 am UTC| Business
PHILADELPHIA and EVRY, France, Sept. 20, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced it has entered...
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
Sep 20, 2017 11:30 am UTC| Business
NEW YORK, Sept. 20, 2017 -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced...